Compare NTRA & AZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | AZO |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4B | 55.2B |
| IPO Year | 2015 | 1998 |
| Metric | NTRA | AZO |
|---|---|---|
| Price | $412.42 | $2,875.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 22 |
| Target Price | $259.07 | ★ $4,306.00 |
| AVG Volume (30 Days) | ★ 1.2M | 359.8K |
| Earning Date | 05-07-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.65 | N/A |
| EPS | N/A | ★ 96.69 |
| Revenue | $210,939,000.00 | ★ $18,938,717,000.00 |
| Revenue This Year | $18.08 | $9.44 |
| Revenue Next Year | $19.65 | $7.72 |
| P/E Ratio | ★ N/A | $29.60 |
| Revenue Growth | N/A | ★ 2.43 |
| 52 Week Low | $157.43 | $2,764.88 |
| 52 Week High | $412.93 | $4,332.68 |
| Indicator | NTRA | AZO |
|---|---|---|
| Relative Strength Index (RSI) | 83.65 | 45.63 |
| Support Level | $187.64 | N/A |
| Resistance Level | N/A | $3,175.48 |
| Average True Range (ATR) | 13.27 | 78.13 |
| MACD | 5.99 | 1.10 |
| Stochastic Oscillator | 95.85 | 47.52 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
AutoZone operates as a leading retailer of aftermarket automotive parts in the United States. The firm operates 6,666 stores domestically, serving the do-it-yourself and commercial (do-it-for-me) end markets. Through its vast store footprint and distribution network, AutoZone manages a wide array of stock-keeping units applicable to numerous vehicle makes and models, providing its consumers with ample product availability. The firm drives traffic by providing superior and convenient customer service as AutoZone's team of knowledgeable staff assists consumers with diagnosing a vehicle's problem, selecting the necessary part for replacement, and occasionally, installation. The company also operates internationally, with 895 stores in Mexico and 149 in Brazil.